Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Page 1,345
preclinical-research-reveals-elevated-estrogen-levels-may-increase-binge
Posted inBiotechnology

Preclinical Research Reveals Elevated Estrogen Levels May Increase Binge

December 30, 2024
The intricate relationship between hormones and behavior has always fascinated researchers, particularly when it comes to understanding how these biochemical…
Read More
ozone-therapy:-revitalizing-recovery-in-sepsis-induced-lung-injury
Posted inBiotechnology

Ozone Therapy: Revitalizing Recovery in Sepsis-Induced Lung Injury

December 30, 2024
In a groundbreaking advancement in the fight against sepsis-induced acute lung injury (ALI), researchers have identified medical ozone therapy as…
Read More
Posted inBiotechnology

Hello world!

December 25, 2024
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Read More
fierce-biotech-fundraising-tracker-’25:-orbis-rings-in-new-year-with-e90m-series-a
Posted inBiotechnology

Fierce Biotech Fundraising Tracker ’25: Orbis rings in new year with €90M series A

December 23, 2024
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled…
Read More
fierce-biotech-layoff-tracker-2025:-cytomx-cuts-team-by-40%
Posted inBiotechnology

Fierce Biotech Layoff Tracker 2025: CytomX cuts team by 40%

December 23, 2024
We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared…
Read More
ikena,-after-tough-year-of-layoffs,-merges-with-inmagene-to-focus-on-phase-2-dermatitis-prospect
Posted inBiotechnology

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect

December 23, 2024
After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found…
Read More
rapt-re-rolls-after-flameout,-paying-$35m-for-challenger-to-novartis,-roche-drug
Posted inBiotechnology

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug

December 23, 2024
Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a…
Read More
sanofi-pays-sk-bioscience-e50m-as-children’s-pneumococcal-vaccine-enters-phase-3
Posted inBiotechnology

Sanofi pays SK bioscience €50M as children’s pneumococcal vaccine enters phase 3

December 23, 2024
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine…
Read More
phase-2-data-will-drive-biopharma-vc-investments-next-year:-pitchbook
Posted inBiotechnology

Phase 2 data will drive biopharma VC investments next year: PitchBook

December 23, 2024
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into…
Read More
Posted inBiotechnology

Discover Astellas’ differentiated approach to innovation partnerships

December 20, 2024
As a global life sciences company, Astellas is passionate about partnering to advance life-changing treatments for patients. If you are…
Read More

Posts pagination

Previous page 1 … 1,343 1,344 1,345 1,346 1,347 … 1,352 Next page

Privacy Policy    Terms

Scroll to Top